Similar articles

• Treatment of hepatitis C virus/HIV coinfection.

  Chun S, Sherman KE. Chun S, et al. Clin Liver Dis. 2005 Aug;9(3):525-33, ix. doi: 10.1016/j.cld.2005.05.008. Clin Liver Dis. 2005. PMID: 16023981 Review.
• Therapy of hepatitis C in HIV-coinfection.

  Rockstroh JK, Vogel M. Rockstroh JK, et al. Eur J Med Res. 2004 Jun 30;9(6):304-8. Eur J Med Res. 2004. PMID: 15257871 Review.
• HIV and hepatitis C coinfection.

  Matthews GV, Dore GJ. Matthews GV, et al. J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 1):1000-8. doi: 10.1111/j.1440-1746.2008.05489.x. J Gastroenterol Hepatol. 2008. PMID: 18707597 Review.
• Anemia during treatment of hepatitis C in HIV-infected patients.

  Lo Re V 3rd, Kostman JR. Lo Re V 3rd, et al. AIDS Read. 2004 Oct;14(10):555-7, 562, 565-71. AIDS Read. 2004. PMID: 15510392 Review.
• High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin.

  Moreno A, Quereda C, Moreno L, Perez-Elías MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, Bárcena R, Moreno S. Moreno A, et al. Antivir Ther. 2004 Feb;9(1):133-8. Antivir Ther. 2004. PMID: 15040545